Autopsy report · NCT02729805

Intraoperative Ketamine on Chronic Pain After Mastectomy

“Not enough patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Suspended: paused, and may or may not restart.
• 135 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 4

Sponsor

The University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Chronic Pain

Interventions

Saline; Ketamine 0.5mg/kg; Ketamine 0.75mg/kg

Participants

135 (planned, not actual)

Sites

1

Countries

Hong Kong

Trials that died the same way

• Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
  “Not enough patients available” (95% match in meaning)
• Epidermal Cells Delivery and Acute Burns
  “Not enough patients included” (93% match in meaning)
• The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham
  “Too few patients included” (85% match in meaning)
• Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
  “too few patients could be included” (83% match in meaning)
• Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
  “Lack of patients” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.